N/A
N=148
Randomized Comparison of Mindfulness Versus Group Support for Treatment of Low Sexual Desire in Women
Low Female Sexual Desire
Bottom Line
View on ClinicalTrials.gov: NCT01690897 ↗Enrolled (actual)
148
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Female Sexual Distress Scale-Revised (FSDS-R) — 22.88; 25.68; 23.02; 23.87 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Mindfulness-based treatment (Behavioral); Sex therapy, education, and support treatment (Behavioral)
- Age
- Adult, Older Adult · 19+ yrs
- Sex
- Female
- Sponsor
- University of British Columbia
- Primary completion
- Dec 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Female Sexual Distress Scale-Revised (FSDS-R) |
22.88; 25.68; 23.02; 23.87; 18.92; 21.60 | — |
| PRIMARY Sexual Interest and Desire Inventory (SIDI) |
27.91; 23.62; 28.08; 25.57; 29.85; 26.76 | — |
| PRIMARY Rumination |
2.60; 2.71; 2.32; 2.81; 2.23; 2.47 | — |
| PRIMARY Relationship Assessment Scale (RAS) |
4.27; 4.03; 3.87; 4.14; 4.16; 4.24 | — |
| SECONDARY Subjective Sexual Arousal |
2.96; 3.21; 3.93; 3.74; 3.8; 3.77 | — |
| SECONDARY Interoceptive Awareness |
2.60; 2.74; 3.15; 2.9; 3.08; 2.89 | — |
| SECONDARY Physiological Sexual Arousal |
.120; .125; .124; .135; .102; .133 | — |
| SECONDARY Stress Hormone Cortisol Slope |
.298; .296; .285; .283; .325; .310 | — |
Summary
The purpose of this study is to determine whether an 8-session mindfulness-based intervention (MBCT group) is effective for women with low sexual interest/desire in reducing sexual distress, improving their sexual response, and increasing their mindful skills, compared to a support group.
Eligibility Criteria
Inclusion Criteria
- must be experiencing distressing sexual interest/desire and/or sexual arousal concerns
- must between the ages of 19 - 65
- must be fluent in English
Exclusion Criteria
- not experiencing distressing sexual interest/desire and/or sexual arousal concerns
- not between the ages of 19-65
- unable to read, write, speak and understand English
Data sourced from ClinicalTrials.gov (NCT01690897). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.